Director, Laboratory for Multiscale Regenerative Technologies
Dr. Bhatia is a Howard Hughes Medical Institute Investigator and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS). Bhatia is the Director of the Marble Center for Cancer Nanomedicine, and a member of the Ludwig Center for Molecular Oncology – both part of the Koch Institute for Integrative Cancer Research at MIT. She is also an Affiliated Faculty member of the Harvard Stem Cell Institute, an Institute Member of the Broad Institute, a Biomedical Engineer at the Brigham & Women's Hospital, and has been elected to Brown University’s Board of Trustees. Trained as both a physician and engineer, Bhatia leads a laboratory dedicated to leveraging miniaturization tools from the world of semiconductor manufacturing to impact human health. She has pioneered technologies for interfacing living cells with synthetic systems, enabling new applications in tissue regeneration, stem cell differentiation, medical diagnostics and drug delivery. Her multidisciplinary team has developed a broad and impactful range of inventions, including human micro livers which model human drug metabolism, liver disease, and interaction with pathogens. Her group also develops nanoparticles and nanoporous materials that can be designed to assemble and communicate to study, diagnose, and treat a variety of diseases, including cancer. Her work has been profiled broadly such as in Scientific American, the Boston Globe, BBC News, TED and TEDMED, Popular Science, Huffington Post, Forbes, PBS’s NOVA scienceNOW, the Economist, and MSNBC.